Director received an award of 18K ADMA derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 9, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 12, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-26-004892
- Filed / recorded
Added to OQROOct 6, 2026, 9:54 PM UTC Data qualityVerified: identifiers matched exactly IssuerADMA BIOLOGICS, INC. Reporting personJerrold B Grossman SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateFeb 9, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.
Around the same time
Traded Mar 6 · filed 5 days later
Routine share withholding; mechanical by default.
Traded Mar 7 · filed 4 days later
Routine share withholding; mechanical by default.
Traded Mar 9 · filed 2 days later
Not classified as an open-market trade.